An excipient is a pharmacologically inactive element which is added along with the API in a particular formulation. It is added so as to provide stability, increase the absorption of the drug and to better other pharmacokinetic properties. There are many excipients available in the market like gelatin, complex sugars and various polymers. Sugar based excipients are the most common of all, and are widely used in parenteral medicines. These excipients try to mask the bitterness of the pharmaceutical drug.
Middle East and Africa Sugar based Excipients Market was worth USD 140.44 million in 2018 and estimated to be growing at a CAGR of 4%, to reach USD 169.89 million by 2023.
The rapidly growing generic drugs market contributes heavily to the excipient market. There has been an increased usage in co-processed excipient and rising improvement of orally disintegrating tablets. These two factors also drive the market.The use of mannitol is also boosting the market. Drug manufacturers are trying to incorporate excipients in the formulations so that they can be easily taken by children and other patients. However, there is a shortage of FDA approved manufacturing sites because of their strict regulations, making this a major restraint to market growth.
Middle East and Africa sugar excipients market is segmented based on type, product, functionality and formulation. Based on type the market is segmented into Powder and granules, Crystal, Syrup and others. Powders and granules accounted for the biggest share in the segment due to its wide use in various formulations. Based on product, the market is segmented into actual sugars, sugar alcohols, and artificial sweeteners. Actual sugar dominated the segment whereas sugar alcohols are to witness fast growth over the forecast period due to a rise in the use of mannitol. On the basis of functionality, the market is segmented into fillers, diluents, flavouring agent and tonicity agents. Fillers and diluents account for the major market share due to their widespread use in tablets and capsules. Based on formulation, the market is segmented into oral, topical and parenteral. Oral formulations dominate this segment due to an increased use of various oral formulations. On the basis of geography, the market is analysed under various regions namely Middle East and Africa. The market size of this region is small as compared to other regions.
Some of the key players of the market are Archer Daniels Midland Company, The Lubrizol Corporation, Ashland Inc., Roquette Group, Associated British Foods Plc, Meggle AG, Basf SE, FMC Corporation, Cargill, Inc., Dfe Pharma, and Colorcon Inc.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Powders and granules
5.1.3 Crystal
5.1.4 Syrup
5.1.5 Others
5.1.6 Y-o-Y Growth Analysis, By Type
5.1.7 Market Attractiveness Analysis, By Type
5.1.8 Market Share Analysis, By Type
5.2 Product
5.2.1 Introduction
5.2.2 Actual sugar
5.2.3 Sugar alcohol
5.2.4 Artificial sweeteners
5.2.5 Y-o-Y Growth Analysis, By Product
5.2.6 Market Attractiveness Analysis, By Product
5.2.7 Market Share Analysis, By Product
5.3 Functionality
5.3.1 Introduction
5.3.2 Filler
5.3.3 Diluent
5.3.4 Flavouring agent
5.3.5 Tonicity agent
5.3.6 Y-o-Y Growth Analysis, By Functionality
5.3.7 Market Attractiveness Analysis, By Functionality
5.3.8 Market Share Analysis, By Functionality
5.4 Formulation
5.4.1 Introduction
5.4.2 Oral
5.4.3 Topical
5.4.4 Parenteral
5.4.5 Y-o-Y Growth Analysis, By Formulation
5.4.6 Market Attractiveness Analysis, By Formulation
5.4.7 Market Share Analysis, By Formulation
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Product
6.1.3.4 By Functionality
6.1.3.5 By Formulation
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Product
6.1.4.4 By Functionality
6.1.4.5 By Formulation
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Product
6.1.5.4 By Functionality
6.1.5.5 By Formulation
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Archer Daniels Midland Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 The Lubrizol Corporation
8.3 Ashland Inc.
8.4 Roquette Group
8.5 Associated British Foods Plc
8.6 Meggle AG
8.7 BASF SE
8.8 Dfe Pharma
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
